×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CCCC – c4 therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CCCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
08:04 am
cccc
C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Medium
Report
C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
12/2
07:10 am
cccc
C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Medium
Report
C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
11/26
06:33 am
cccc
Pipeline Momentum Drives C4 Therapeutics Despite Q3 EPS Miss [Seeking Alpha]
Medium
Report
Pipeline Momentum Drives C4 Therapeutics Despite Q3 EPS Miss [Seeking Alpha]
11/25
07:00 am
cccc
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
Low
Report
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
11/21
05:17 pm
cccc
C4 Therapeutics files $400M mixed shelf offering [Seeking Alpha]
Medium
Report
C4 Therapeutics files $400M mixed shelf offering [Seeking Alpha]
11/6
07:00 am
cccc
C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Low
Report
C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
10/17
09:00 am
cccc
Precision Oncology Approaches Drive $312B Market Transformation
Medium
Report
Precision Oncology Approaches Drive $312B Market Transformation
10/17
09:00 am
cccc
Precision Oncology Approaches Drive $312B Market Transformation
Medium
Report
Precision Oncology Approaches Drive $312B Market Transformation
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
06:08 pm
cccc
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
11/6
07:13 am
cccc
Form 10-Q C4 Therapeutics, Inc. For: Sep 30
Low
Report
Form 10-Q C4 Therapeutics, Inc. For: Sep 30
11/6
07:07 am
cccc
Form 8-K C4 Therapeutics, Inc. For: Nov 06
Low
Report
Form 8-K C4 Therapeutics, Inc. For: Nov 06
10/30
04:30 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Oct 28 Filed by: Mahaney Paige
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Oct 28 Filed by: Mahaney Paige
10/24
04:30 pm
cccc
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
Medium
Report
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
10/24
04:13 pm
cccc
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
10/20
07:02 pm
cccc
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Medium
Report
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: